<?xml version="1.0" encoding="UTF-8"?>


  <rss version="2.0">
     <channel>
        <title>intervet.com - News</title>
        <link>http://www.intervet.com/</link>
        <description>
            Intervet / Schering-Plough Animal Health
         </description>
         <language>en-us</language>
         <lastBuildDate>Thu, 31 Dec 2015 22:29:39 GMT</lastBuildDate>
         <docs>http://backend.userland.com/rss2</docs>
         <generator>intervet.com RSS feed generator</generator>
         <category>Articles</category>
        <image>
           <title>intervet.com - News</title>
           <url>http://www.intervet.com/binaries/INTSPAH_logo_CMYK_RED_BLK_tcm50-169935.gif</url>
           <link>http://www.intervet.com/</link>
        </image>
         
         <item>
            <title>Sanofi-aventis and Merck appoint Raul Kohan as CEO for the new Animal Health joint venture</title>
            <link>http://www.intervet.com/news/2010-07-27-announcement-raul-kohan-ceo-joint-venture.aspx</link>
            <description>Paris, France and Whitehouse Station, NJ – July 27, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Merck &amp; Co., Inc. (NYSE: MRK) announced today that Raul E. Kohan will be appointed Chief ...</description>
            <pubDate>27 July 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health demonstrates efficacy of simultaneous use of circovirus and mycoplasma vaccines in swine</title>
            <link>http://www.intervet.com/news/2010-07-22-ipvs-2010.aspx</link>
            <description>Simultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and ...</description>
            <pubDate>22 July 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Deltamethrin-impregnated collar provides a cost-effective solution to control canine and human Leishmaniasis</title>
            <link>http://www.intervet.com/news/2010-06-23-scalibor-cost-effectiveness-brazil-2010.aspx</link>
            <description>BOXMEER (The Netherlands) June 23, 2010 - Delegates at the 2nd International Congress on Canine Leishmaniasis, which was recently held in the Italian city of Pisa, heard how a readily-available deltamethrin-impregnated ...</description>
            <pubDate>23 June 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health receives positive opinion in Europe for simultaneous use of PORCILIS PRRS and PORCILIS M Hyo vaccines in piglets</title>
            <link>http://www.intervet.com/news/2010-06-22-positive-opinion-eu-porcilis-prrs-plus-porcilis-mhyo.aspx</link>
            <description>BOXMEER (the Netherlands), June 22, 2010 – Intervet/Schering-Plough Animal Health, announces today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency ...</description>
            <pubDate>22 June 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Dieter Lütticken Award 2009 for development of in vitro bovine respiratory tract organ culture model</title>
            <link>http://www.intervet.com/news/2010-06-09-dla-2009.aspx</link>
            <description>BOXMEER (Netherlands), June 9, 2010 – The Dieter Lütticken Award 2009, a prestigious international annual award dedicated to alternatives in animal testing for veterinary medicines, goes to Dr. A.W. (Dan) ...</description>
            <pubDate>9 June 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Equine strangles vaccine returns to the market in Europe</title>
            <link>http://www.intervet.com/news/2010-06-01-equine-strangles-vaccine-relaunch.aspx</link>
            <description>BOXMEER (the Netherlands), June 1, 2010 – Intervet/Schering-Plough Animal Health, the European market leader in equine vaccines, today announces that it is re-introducing EQUILIS® StrepE, the only strangles ...</description>
            <pubDate>1 June 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Study shows cost-effectiveness of RESFLOR in feedlot cattle treated for undifferentiated fever related to Bovine Respiratory Disease</title>
            <link>http://www.intervet.com/news/2010-05-27-resflor-cost-effectiveness-study-2010.aspx</link>
            <description>BOXMEER (Netherlands), May 27, 2010 – In a Canadian field trial in feedlot cattle recently published in Veterinary Therapeutics, it was demonstrated that treatment of undifferentiated fever related to ...</description>
            <pubDate>27 May 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health introduces the SLICE Sustainability Project at Sea Lice 2010</title>
            <link>http://www.intervet.com/news/2010-05-10-slice-sustainability-project-2010.aspx</link>
            <description>BOXMEER (The Netherlands), May 10, 2010 — Intervet/Schering-Plough Animal Health has introduced the SLICE® Sustainability Project, a comprehensive, six-step integrated strategy to help the world’s salmon ...</description>
            <pubDate>10 May 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Pancreatic disease vaccine patent of Intervet/Schering-Plough Animal Health upheld by Oslo District Court</title>
            <link>http://www.intervet.com/news/2010-04-29-pancreatic-disease-vaccine-patent-litigation.aspx</link>
            <description>BOXMEER (Netherlands) and OSLO (Norway), April 29, 2010 – Intervet/Schering-Plough Animal Health announces today that the Oslo District Court has ruled that its Pancreatic Disease (PD) patent NO 317.547 ...</description>
            <pubDate>29 April 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health opens state-of-the-art vaccine manufacturing facility at Biosciences Center Boxmeer</title>
            <link>http://www.intervet.com/news/2010-04-22-opening-bacteriological-processing.aspx</link>
            <description>BOXMEER (Netherlands), April 22, 2010 – Intervet/Schering-Plough Animal Health announces that it will open today a state-of-the-art production center for veterinary vaccines against bacterial infections. ...</description>
            <pubDate>22 April 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Consortium receives research grant from the Wellcome Trust to develop improved vaccines against foot-and-mouth disease</title>
            <link>http://www.intervet.com/news/2010-04-01-broadcasting-website-mastitis-conference.aspx</link>
            <description>BOXMEER (Netherlands), April 1, 2010 – An international collaborative group of research institutions and industry today announces that it has received approximately US$ 2 million from the Wellcome Trust ...</description>
            <pubDate>1 April 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Broadcasting website offers dairy professionals virtual presence at international mastitis conference in New Zealand</title>
            <link>http://www.intervet.com/news/2010-03-19-broadcasting-website-mastitis-conference.aspx</link>
            <description>Boxmeer, March 19, 2010 - Intervet/Schering-Plough Animal Health launches the website Studio Recharge, broadcasting to the global dairy community from the 5th International Dairy Federation (IDF) Mastitis ...</description>
            <pubDate>19 March 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Sanofi-aventis and Merck to create a Global Leader in Animal Health</title>
            <link>http://www.intervet.com/news/2010-03-09-sanofi-aventis-and-merck-to-create-a-global-leader-in-animal-health.aspx</link>
            <description>Sanofi-aventis exercises its option to combine Merial with Intervet/Schering-Plough in a new equally-owned Joint Venture with MerckParis, France and Whitehouse Station, NJ. – March 9, 2010 – Sanofi-aventis ...</description>
            <pubDate>9 March 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intestinal Health Center for Poultry website offers rich content, dynamic features</title>
            <link>http://www.intervet.com/news/2010-01-27-intestinal-health-center-for-poultry-website-offers-rich-content-dynamic-features.aspx</link>
            <description>BOXMEER (Netherlands), January 27, 2010 – Intervet/Schering-Plough Animal Health has launched the Intestinal Health Center for Poultry website (www.ihc-poultry.com), a dedicated website to keep producers, ...</description>
            <pubDate>27 January 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health receives European approval for a single-shot dosage scheme of PORCILIS PCV</title>
            <link>http://www.intervet.com/news/2010-01-26-porcilis-pcv-eu-single-shot.aspx</link>
            <description>BOXMEER (Netherlands), January 26, 2010 – Intervet/Schering-Plough Animal Health today announces that it has received marketing authorization from the European Commission on January 12, 2010 for a single-shot ...</description>
            <pubDate>26 January 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Symposium shows importance of managing Bovine Respiratory Disease 'right first time' with combination treatment</title>
            <link>http://www.intervet.com/news/2010-01-13-resflor-in-brd.aspx</link>
            <description>BOXMEER (Netherlands), January 13, 2010 – Treatment of Bovine Respiratory Disease (BRD) in cattle with a combination preparation consisting of the anti-infective drug florfenicol and the anti-inflammatory ...</description>
            <pubDate>13 January 2010</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Carbimazole (VIDALTA) treatment in cats with hyperthyroidism normalizes thyroid hormone levels and improves clinical signs</title>
            <link>http://www.intervet.com/news/2009-11-25-vidalta-efficacy-manuscript.aspx</link>
            <description>BOXMEER (the Netherlands), November 25, 2009 — Treatment of hyperthyroidism in cats with VIDALTA® - a novel, once-daily oral formulation of carbimazole - reduces thyroid hormone concentrations, bringing ...</description>
            <pubDate>25 November 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>New Merck Begins Operations - With robust pipeline, broader product portfolio and expanded global presence</title>
            <link>http://www.intervet.com/news/2009-11-04-new-merck-begins-operations.aspx</link>
            <description>WHITEHOUSE STATION, N.J. – November 4, 2009 – Merck &amp; Co., Inc. (NYSE: MRK) today outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation announced yesterday.  ...</description>
            <pubDate>4 November 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Symposium at World Aquaculture 2009 offers integrated solutions for managing rising streptococcus infections in warmwater fish</title>
            <link>http://www.intervet.com/news/2009-11-02-aqua-veracruz-symposium.aspx</link>
            <description>Proceedings available from Intervet/Schering-Plough Animal HealthBOXMEER (the Netherlands), November 2, 2009 — Proceedings from a recent symposium that offered integrated health solutions for managing ...</description>
            <pubDate>2 November 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough announces sponsorship of rabies-control project in India</title>
            <link>http://www.intervet.com/news/2009-11-02-rabies-control-sponsorship-project-india.aspx</link>
            <description>KENILWORTH, N.J., Nov. 2, 2009 – Schering-Plough Corporation (NYSE: SGP) today announced it has initiated sponsorship of two projects in India to reduce the incidence of human and animal rabies through ...</description>
            <pubDate>2 November 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>New data support use of BUTOX in cattle and sheep exposed to wet conditions to protect against biting midges</title>
            <link>http://www.intervet.com/news/2009-10-30-butox-rain-protection.aspx</link>
            <description>BOXMEER (the Netherlands), October 30, 2009 – A new study has demonstrated that the veterinary antiparasitic product BUTOX® 7.5 pour on (deltamethrin) also protects cattle and sheep during wet conditions ...</description>
            <pubDate>30 October 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health announces sponsorship supporting milk producers in Malawi</title>
            <link>http://www.intervet.com/news/2009-10-08-shmpa-support.aspx</link>
            <description>BOXMEER (the Netherlands), October 8, 2009 — Intervet/Schering-Plough Animal Health today announced that it has initiated a multy-year sponsorship project, supporting the Shire Highlands Milk Producers ...</description>
            <pubDate>8 October 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health completes first wave of launches of VECTIN, an antiparasitic drug for horses formulated as a tasty cookie</title>
            <link>http://www.intervet.com/news/2009-09-29-vectin-launch.aspx</link>
            <description>BOXMEER (the Netherlands), September 29, 2009 — Intervet/Schering-Plough Animal Health today announces that it has completed the first wave of market introductions of VECTIN® (ivermectin chewable tablets), ...</description>
            <pubDate>29 September 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Dieter Lütticken Award 2008 for Alternatives in Animal Testing presented to Dr. Ivo Claassen (the Netherlands)</title>
            <link>http://www.intervet.com/news/2009-09-03-dl-award-2008-ceremony.aspx</link>
            <description>ROME (Italy), September 3, 2009 — The Dieter Lütticken Award 2008 for alternatives in animal testing was presented today to Dr. Ivo Claassen for developing an alternative quality control method for poultry ...</description>
            <pubDate>3 September 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Sanofi-aventis to acquire Merck's interest in Merial</title>
            <link>http://www.intervet.com/news/copy_of_2009-06-23-new-vaccine-from-intervet-schering-plough-animal-health-is-first-for-canine-influenza-virus.aspx</link>
            <description>Agreement includes option for sanofi-aventis to combine Merial with Intervet/Schering-Plough Animal Health in new equally owned joint venture with the new MerckFuture joint venture would be a global leader ...</description>
            <pubDate>30 July 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Vaccine Against Canine Flu Granted Conditional License by USDA</title>
            <link>http://www.intervet.com/news/2009-06-23-new-vaccine-from-intervet-schering-plough-animal-health-is-first-for-canine-influenza-virus.aspx</link>
            <description>ROSELAND, N.J., June 23, 2009 – Intervet/Schering-Plough Animal Health, the global leader in veterinary biologicals, today announced the availability of the first vaccine against canine influenza virus ...</description>
            <pubDate>23 June 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health introduces NOBIVAC Lyme, a unique vaccine providing dogs with dual protection</title>
            <link>http://www.intervet.com/news/2009-06-15.aspx</link>
            <description>ROSELAND, N.J., June 15, 2009 – Intervet/Schering-Plough Animal Health announced the introduction of NOBIVAC Lyme. This new-generation Lyme vaccine is the only vaccine specifically designed to provide ...</description>
            <pubDate>17 June 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health's new INNOVAX poultry vaccine range now available in Latin America</title>
            <link>http://www.intervet.com/news/2009-06-10-innovax-latin-american-launches.aspx</link>
            <description>BOXMEER (the Netherlands), June 10, 2009 — Intervet/Schering-Plough Animal Health, the global leader in animal health solutions, announces today that its innovative recombinant INNOVAX® poultry vaccine ...</description>
            <pubDate>10 June 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>European Mastitis Panel calls for harmonization of mastitis diagnosis in dairy cattle</title>
            <link>http://www.intervet.com/news/2009-06-09-european-mastitis-panel.aspx</link>
            <description>BOXMEER (The Netherlands), June 9, 2009 − Harmonization of diagnostic procedures of mastitis (udder infection) in dairy cattle is much needed. This was one of the conclusions drawn at the 2nd annual meeting ...</description>
            <pubDate>9 June 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health continues to support the Afya Serengeti rabies project - Children join the fight to eradicate rabies</title>
            <link>http://www.intervet.com/news/2009-06-04-afya-serengeti-t-shirt-contest.aspx</link>
            <description>BOXMEER (The Netherlands), June 4, 2009 - Eradication of rabies remains firmly on the agenda for Intervet/Schering-Plough Animal Health as the company launches its latest campaign to support the Afya ...</description>
            <pubDate>4 June 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>PORCILIS PCV swine vaccine against porcine circovirus type 2 infection launched in Europe</title>
            <link>http://www.intervet.com/news/2009-04-23-porcilis-pcv-eu-launch.aspx</link>
            <description> BOXMEER (the Netherlands), April 23, 2009 — Intervet/Schering-Plough Animal Health today announces the introduction in Europe of its PORCILIS PCV vaccine against porcine circovirus type 2 (PCV2) infection. ...</description>
            <pubDate>23 April 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Dieter Lütticken Award 2008 recognizes development of new vaccine quality control assay</title>
            <link>http://www.intervet.com/news/2009-04-07-dieter-luetticken-award-announced.aspx</link>
            <description>BOXMEER (the Netherlands), April 7, 2009 — Intervet/Schering-Plough Animal Health today announces that the Dieter Lütticken Award 2008 for alternatives in animal testing goes to Dr. Ivo Claassen for a ...</description>
            <pubDate>7 April 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health sponsors peer-reviewed website on chicken anemia virus</title>
            <link>http://www.intervet.com/news/2009-03-11-intervet-schering-plough-animal-health-focus-on-poultry-disease-management.aspx</link>
            <description>A peer-reviewed website about chicken infectious anemia has been launched under the sponsorship of Intervet/Schering-Plough Animal Health. The website — www.chicken-anemia.com — is intended to give poultry ...</description>
            <pubDate>11 March 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health to focus on four areas of poultry-disease management</title>
            <link>http://www.intervet.com/news/2009-01-29-intervet-schering-plough-animal-health-focus-on-poultry-disease-management.aspx</link>
            <description>Intervet/Schering-Plough Animal Health has segmented its poultry-product line into four areas — food safety, immune-system defense, intestinal health and respiratory protection — to help focus its resources ...</description>
            <pubDate>29 January 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health names global, regional support teams for poultry</title>
            <link>http://www.intervet.com/news/2009-01-29-intervet-schering-plough-animal-health-names-poultry-teams.aspx</link>
            <description>ATLANTA, GA (USA) and BOXMEER (The Netherlands), January 29, 2009 — Intervet/Schering-Plough Animal Health has announced the following appointments for its Global Poultry Business Unit:• Dr. Marcelo Lang ...</description>
            <pubDate>29 January 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health opens manufacturing facility for innovative poultry vaccine technology</title>
            <link>http://www.intervet.com/news/2009-01-27-intervet-schering-plough-animal-health-opens-manufacturing-facility.aspx</link>
            <description>Dutch minister of Agriculture, Nature and Food Quality, Mrs. Gerda Verburg, visits animal health headquarters in Boxmeer and opens SPHEREON® facilityBOXMEER (The Netherlands), January 27, 2009 – Intervet/Schering-Plough ...</description>
            <pubDate>27 January 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Partners In Practice - Leaders from Intervet/Schering-Plough Animal Health U.S. provide updates on the new combined business at NAVC 2009</title>
            <link>http://www.intervet.com/news/2009-01-20-partners-in-practice.aspx</link>
            <description>Orlando, FL, January 20, 2009 – Leaders from the U.S. division of Intervet/Schering-Plough Animal Health discussed the new combined company at an event held at this year’s North American Veterinary Conference. ...</description>
            <pubDate>20 January 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>2008 Seasons Greetings donation for APOPO’s sniffer rats</title>
            <link>http://www.intervet.com/news/2008-11-12.aspx</link>
            <description>Every year, instead of traditional Season’s Greetings cards, Intervet/Schering-Plough Animal Health supports charitable projects or organizations with activities that benefit animal welfare and people. ...</description>
            <pubDate>12 November 2008 - 1 January 2009</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough Announces Transition of Animal Health Leadership</title>
            <link>http://www.intervet.com/news/2008-10-17.aspx</link>
            <description>KENILWORTH, N.J., Oct. 17, 2008 – Schering-Plough Corporation (NYSE: SGP) today announced the transition of leadership of its Animal Health unit from Ruurd Stolp, D.V.M., Ph.D., to Raul E. Kohan, who ...</description>
            <pubDate>17 October 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health extends its portfolio with LEVENTA® and supports veterinary endocrinology</title>
            <link>http://www.intervet.com/news/2008-10-09-ispah-launches-leventa.aspx</link>
            <description>BOXMEER (the Netherlands), October 9, 2008 – As the global leader in the field of veterinary endocrinology, Intervet/Schering-Plough Animal Health today announces a further extension to its portfolio ...</description>
            <pubDate>9 October 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health introduces Porcilis® COLI 6C swine vaccine against E. coli and Clostridium perfringens</title>
            <link>http://www.intervet.com/news/2008-09-15-ispah_introduces_porcilis_coli_c6.aspx</link>
            <description>BOXMEER (the Netherlands), September 15, 2008 – Intervet/Schering-Plough Animal Health today announced the introduction of Porcilis® COLI 6C, a swine vaccine against E. coli and Clostridium perfringens.  The ...</description>
            <pubDate>15 September 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough announces closing of planned divestiture of selected Animal Health products to Pfizer</title>
            <link>http://www.intervet.com/news/2008-09-10-sp_announces_closing_divestiture_selected_products_to_pfizer.aspx</link>
            <description>KENILWORTH, N.J., September 10, 2008 – Schering-Plough Corporation (NYSE: SGP) today announced the successful closing of its previously announced transaction with Pfizer Animal Health, to divest certain ...</description>
            <pubDate>10 September 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health shows innovative portfolio at WSAVA congress, Dublin - Hubert Trentesaux appointed as head of Global Companion Animal</title>
            <link>http://www.intervet.com/news/2008-08-20-ispah_wsava_trentesaux.aspx</link>
            <description>BOXMEER (the Netherlands), August 20, 2008 – At the 33rd annual World Small Animal Veterinary Association Congress (WSAVA)  in Dublin, Ireland, August 20-24, Intervet/Schering-Plough Animal Health, presents ...</description>
            <pubDate>20 August 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health Scholarship on Equine and Critical Care - First European Equine Emergency and Critical Care Scholarship launched in Ireland</title>
            <link>http://www.intervet.com/news/2008-07-28-ispah_scholarship_on_equine_emergency_and_critical_care.aspx</link>
            <description>BOXMEER (the Netherlands), July 28, 2008 - A new scholarship on Equine Emergency and Critical Care has been started at a specialist equine hospital in County Kildare, at the heart of Ireland’s horse-racing ...</description>
            <pubDate>28 July 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health shows broad and innovative portfolio at World Buiatrics Congress - Edival Santos appointed as Head of Global Cattle</title>
            <link>http://www.intervet.com/news/2008-07-07-ispah_shows_broad_and_innovative_portfolio_at_world_buiatrics_congress.aspx</link>
            <description>BOXMEER (the Netherlands), July 07, 2008 – At the 25th World Buiatrics Congress in Hungary, July 6-11, Intervet/Schering-Plough Animal Health, market leader in beef, dairy and small ruminants sectors, ...</description>
            <pubDate>7 July 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough announces closing of planned divestiture of selected Animal Health products</title>
            <link>http://www.intervet.com/news/2008-07-02-sp_announces_closing_divestiture_selected_products.aspx</link>
            <description>KENILWORTH, N.J., July 2, 2008 – Schering-Plough Corporation (NYSE: SGP) today announced the successful closing of its previously announced transaction with Virbac, S.A. to divest animal health products ...</description>
            <pubDate>2 July 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health appoints Heads of Global Species teams for swine, poultry and aquaculture</title>
            <link>http://www.intervet.com/news/2008-05-27-ispah_appoints_heads_species_teams.aspx</link>
            <description>BOXMEER (the Netherlands), May 27, 2008 – Intervet/Schering-Plough Animal Health appointed the Heads of Global Species teams for the swine, the poultry and the aquaculture segment. These appointments ...</description>
            <pubDate>28 May 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Prof. Dr. George Gettinby honored with Dieter Lütticken Award</title>
            <link>http://www.intervet.com/news/2008-05-19-dieter_luetticken_award_winner.aspx</link>
            <description>BOXMEER (the Netherlands), May 19, 2008 - At the 'World Aquaculture 2008”, held on May 19 -23 in Busan, Korea, Prof. Dr. George Gettinby from the University of Strathclyde, Scotland, United Kingdom, was ...</description>
            <pubDate>19 May 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health formed worldwide region teams to support specific regional market needs</title>
            <link>http://www.intervet.com/news/2008-05-14-ispah_formed_worldwide_region_teams.aspx</link>
            <description>BOXMEER (the Netherlands), May 14, 2008 – Intervet / Schering-Plough Animal Health has formed worldwide region teams that will support the market needs of the animal health business in these areas. Hugo ...</description>
            <pubDate>14 May 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health appoints Executive Team</title>
            <link>http://www.intervet.com/news/2008-05-08-ispah_appoints_executive_team.aspx</link>
            <description>BOXMEER (the Netherlands), May 08, 2008 – Schering-Plough appointed the Executive Team members of the company’s global animal health unit: Intervet / Schering- Plough Animal Health. These appointments ...</description>
            <pubDate>8 May 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet/Schering-Plough Animal Health outlines strength of the combination - First batch of bluetongue Bovilis BTV8 vaccine released to supply Northern European countries</title>
            <link>http://www.intervet.com/news/2008-04-29-ispah_outlines_strength_of_the_combination.aspx</link>
            <description>BOXMEER (the Netherlands), April 29, 2008 – Intervet/Schering-Plough Animal Health released the first batch of Bovilis BTV8 vaccine against bluetongue to supply in Northern Europe. The animal health company, ...</description>
            <pubDate>29 April 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough announces planned divestiture of select animal health products in Europe</title>
            <link>http://www.intervet.com/news/2008-04-23.aspx</link>
            <description>KENILWORTH, N.J., April 23, 2008 – Schering-Plough Corporation (NYSE: SGP) today announced two agreements to divest animal health products from 12 product franchises in Europe.  These agreements are in ...</description>
            <pubDate>23 April 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Prof. Dr. George Gettinby wins Dieter Luetticken Award</title>
            <link>http://www.intervet.com/news/2008-03-17-gettinby-dl-award.aspx</link>
            <description>BOXMEER (the Netherlands), March 17, 2008 – Intervet’s Dieter Lϋtticken Award has been granted to Prof. Dr. George Gettinby from the University of Strathclyde, Scotland, United Kingdom. Gettinby’s innovative ...</description>
            <pubDate>17 March 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet will supply French government with a minimum quantity of 27 million doses of Bluetongue vaccine</title>
            <link>http://www.intervet.com/news/2008-02-29-2008-02-29-intervet_will_supply_french_government_with_a_minimum_quantity_of_27_million_doses_of_bluetongue_vaccine.aspx</link>
            <description>ANGERS (France), February 29, 2008 – Today, Intervet received an official order of the Department for Agriculture and Fishery, France, to supply inactivated vaccine against Bluetongue, serotype 8.Intervet ...</description>
            <pubDate>29 February 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet takes the lead in veterinary endocrinology at NAVC</title>
            <link>http://www.intervet.com/news/2008-01-27-intervet_takes_the_lead_in_veterinary_endocrinology_at_navc.aspx</link>
            <description>ORLANDO, FL, February 27, 2008 – As part of its global program to encourage continuing education and research in the field of veterinary internal medicine, Intervet International, a part of Schering-Plough, ...</description>
            <pubDate>27 February 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough &amp; Intervet together for better care</title>
            <link>http://www.intervet.com/news/2008-01195-schering-plough-and-intervet-together-for-better-care.aspx</link>
            <description>ORLANDO, FL, January 19, 2008 –Throughout its history, Schering-Plough has focused on discovering and developing innovative new therapies in the human prescription, animal health and consumer health customer ...</description>
            <pubDate>19 January 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet has developed Bluetongue vaccine</title>
            <link>http://www.intervet.com/news/2008-01-16-intervet-has-developed-bluetongue-vaccine.aspx</link>
            <description>BOXMEER (the Netherlands), January 16, 2008 – Animal health company Intervet International bv, part of Schering-Plough Corporation, has developed a vaccine against Bluetongue serotype 8, for sheep and ...</description>
            <pubDate>16 January 2008</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>INNOVAX™ successfully launched in the US</title>
            <link>http://www.intervet.com/news/2007-11-20.aspx</link>
            <description>INNOVAX™, the new innovative family of vaccines to aid in the prevention of very virulent Mareks Disease, Newcastle Disease and Infectious Laryngotracheitis (ILT), were launched successfully at the American ...</description>
            <pubDate>20 November 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>World Dairy Expo Dairyman of the Year, Industry Person of the Year Award Winners Announced</title>
            <link>http://www.intervet.com/news/2007-10-01b.aspx</link>
            <description>Frank Regan, Waukon, Iowa, Dairyman of the Year, Steve Larson, Fort Atkinson, Wisconsin, Industry Person of the YearThe winners of the 2007 World Dairy Expo Dairyman of the Year and Industry Person of ...</description>
            <pubDate>1 October 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Prof. Mark Stevens honored with Dieter Lütticken Award</title>
            <link>http://www.intervet.com/news/2007-06-29-prof.-mark-stevens-honored-with-dieter-luetticken-award.aspx</link>
            <description>British scientist awarded for excellent contribution to the principle of 3Rs for the development and production of veterinary medicinal productsBoxmeer, August 24, 2007 – At the '6th World Congress on ...</description>
            <pubDate>24 August 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet opens formulation and filling unit at its international competence center for Foot and Mouth Disease</title>
            <link>http://www.intervet.com/news/2007-06-29-intervet-opens-formulation-and-filling-unit-at-its-international-competence-center-for-foot-and-mouth-disease.aspx</link>
            <description>Today, Intervet, largest vaccine producer world wide, opens a new formulation and filling unit at the Foot and Mouth Disease (FMD) vaccine factory in Cologne, Germany. With this factory Intervet substantially ...</description>
            <pubDate>29 June 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet Dieter Luetticken Award</title>
            <link>http://www.intervet.com/news/2007-06-22-intervet-dieter-luetticken-award-2008.aspx</link>
            <description>Intervet’s award to reduce the number of animals used in testing for development and production of animal veterinary medicinesIntervet offers the Dieter Lütticken award to promote scientists or life science ...</description>
            <pubDate>22 June 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet's bird flu vaccine receives EU license</title>
            <link>http://www.intervet.com/news/intervets-bird-flu-vaccine-receives-eu-license.aspx</link>
            <description>Intervet, a leading animal health company, received approval for its bird flu (avian influenza) vaccine Nobilis® Influenza H7N1. As a result, Europe now has a licensed vaccine to protect birds against ...</description>
            <pubDate>11 May 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Dieter Luetticken Award Winner</title>
            <link>http://www.intervet.com/news/2007-05-03-dieter-luetticken-award-winner.aspx</link>
            <description>The annual Dieter Lütticken Award, has been granted to Dr Mark Stevens from the Institute of Animal Health, United Kingdom for his commitment to advancing the 3R concept – reducing, refining or replacing ...</description>
            <pubDate>3 May 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>New AQUAFLOR®-CA1 Conditionally Approved by FDA for Controlling Columnaris in Catfish</title>
            <link>http://www.intervet.com/news/2007-04-16b.aspx</link>
            <description>First and only catfish antibiotic approved for highly prevalent and costly bacterial diseaseSchering-Plough Animal Health Corporation has introduced AQUAFLOR®-CA1 (florfenicol), the first and only in-feed ...</description>
            <pubDate>16 April 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>AQUAFLOR® (florfenicol) Approved for Freshwater-reared Salmonids</title>
            <link>http://www.intervet.com/news/2007-03-21b.aspx</link>
            <description>First and only antibiotic in U.S. for coldwater diseaseAQUAFLOR® (florfenicol), the first new in-feed antibiotic licensed for U.S. aquaculture in more than two decades, has become the first and only antibiotic ...</description>
            <pubDate>21 March 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet opens new production facility for vaccines</title>
            <link>http://www.intervet.com/news/intervet-opens-new-production-facility-for-vaccines.aspx</link>
            <description>Intervet, the world’s largest producer of vaccines for animals, will open a production facility for vaccines in Boxmeer, the Netherlands, today. This will strengthen Boxmeer’s position as Intervet’s largest ...</description>
            <pubDate>29 January 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet organizes two international symposia at NAVC</title>
            <link>http://www.intervet.com/news/2005-01-15-intervet-organizes-two-international-symposia-at-navc.aspx</link>
            <description>Orlando, January 15, 2007 – As part of its global program to encourage continuing education and research in the field of veterinary internal medicine, Intervet organized two international symposia at ...</description>
            <pubDate>15 January 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Protection and immune response in pigs intradermally vaccinated against PRRS and subsequently exposed to a heterologous European field strain.</title>
            <link>http://www.intervet.com/news/2007-01-08.aspx</link>
            <description>Porcilis PRRS is the subject of an article in the journal Vaccine 25 (2007). Professor Paolo Martelli of Parma University supports the efficacy of Porcilis PRRS against a heterologous challenge, and offers ...</description>
            <pubDate>8 January 2007</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet appoints Jochen Bader Vice President Finance and Control</title>
            <link>http://www.intervet.com/news/intervet-appoints-jochen-bader-vice-president-finance-and-control.aspx</link>
            <description>Intervet, the animal health business unit of Akzo Nobel, appointed the current Director Finance and Control, Jochen Bader (46), Vice President Finance and Control. After graduating from ‘Fachhochschule’ ...</description>
            <pubDate>15 November 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet appoints Malte Greune as a member of the company's Executive Committee</title>
            <link>http://www.intervet.com/news/intervet-appoints-malte-greune-as-a-member-of-the-companys-executive-committee.aspx</link>
            <description>Intervet, Akzo Nobel’s veterinary pharma business, announces that Malte Greune (41) has been appointed as a member of Intervet’s Executive Committee. Malte Greune will succeed Joost Helsen in the function ...</description>
            <pubDate>15 November 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet launches innovative equine flu vaccines</title>
            <link>http://www.intervet.com/news/2006-11-01-prequenza.aspx</link>
            <description>Equine influenza continues to be the most common viral respiratory disease found in horses and is endemic in many populations throughout the world.  And, with several recent outbreaks, prevention has ...</description>
            <pubDate>1 November 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Avian influenza research Intervet supported by European Commission</title>
            <link>http://www.intervet.com/news/2006-10-20-ai-research-intervet-supported-by-ec.aspx</link>
            <description>Boxmeer, the Netherlands, October 20, 2006 – This week the European Commission decided to support 17 projects on avian influenza under the EU’s Sixth Research Framework Program. One of the selected projects ...</description>
            <pubDate>20 October 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet supports ECVIM-CA and ESVE</title>
            <link>http://www.intervet.com/news/2009-10-05-intervet-supports-ecvim-ca-and-esve.aspx</link>
            <description>Boxmeer, October 5, 2006 – Intervet presented two awards during ECVIM-CA annual congress and ESVE meeting, as part of its annual sponsorship program to encourage research in the fields of veterinary internal ...</description>
            <pubDate>5 October 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet appoints Ellen de Brabander as a member of the company’s Executive Committee</title>
            <link>http://www.intervet.com/news/intervet-appoints-ellen-de-brabander-as-a-member-of-the-companys-executive-committee.aspx</link>
            <description>Intervet, Akzo Nobel’s veterinary pharma business, announces that Ellen de Brabander – van den Berg (43) has been appointed as a member of Intervet’s Executive Committee, effective October 1, 2006. Ellen ...</description>
            <pubDate>4 October 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet’s equine West Nile vaccine approved by USDA</title>
            <link>http://www.intervet.com/news/2006-09-14_-_intervet_s_equine_west_nile_vaccine_approved_by_usda.aspx</link>
            <description>An equine vaccine developed by Akzo Nobel’s animal health business Intervet, which is indicated for use in horses at risk from West Nile virus has been approved by the United States Department of Agriculture ...</description>
            <pubDate>14 September 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet’s avian flu vaccine licensed for use in European Union</title>
            <link>http://www.intervet.com/news/2006-09-01_-_intervet_s_avian_flu_vaccine_licensed_for_use_in_european_union.aspx</link>
            <description>Intervet’s vaccine is based on a different strain (H5N2) than the current field strain (H5N1). Birds vaccinated with H5N2 form a different set of antibodies than those birds infected with H5N1. These ...</description>
            <pubDate>1 September 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet Receives FDA Approval for Zilmax</title>
            <link>http://www.intervet.com/news/2006-08-21_-_intervet_receives_fda_approval_for_zilmax.aspx</link>
            <description>Intervet’s U.S. business (Intervet Inc.) has received approval from the U.S. Food and Drug Administration (FDA) for Zilmax (zilpaterol hydrochloride), a product designed to improve production efficiencies ...</description>
            <pubDate>21 August 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet continues to invest in Saxe Gotha business park in Boxmeer</title>
            <link>http://www.intervet.com/news/2006-07-27_-_intervet_continues_to_invest_in_saxe_gotha_business_park.aspx</link>
            <description>On 27 July 2006, Intervet purchased the Plukon site at Saxe Gotha business park in Boxmeer. Covering over four hectares, the site is located opposite Intervet’s facilities. Thanks to this purchase, Intervet ...</description>
            <pubDate>27 July 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Citing Special Need, USDA Issues Conditional License for Poultry Industry’s First Vaccine for Necrotic Enteritis</title>
            <link>http://www.intervet.com/news/2006-06-25b.aspx</link>
            <description>Schering-Plough Animal Health Now Field Testing Product in USSchering-Plough Animal Health Corporation has obtained a conditional license from the U.S. Department of Agriculture to begin field testing ...</description>
            <pubDate>25 July 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Foot-and-Mouth disease vaccine factory now owned by Intervet</title>
            <link>http://www.intervet.com/news/2006-07-05_-_foot-and-mouth_disease_vaccine_factory_now_owned_by_intervet.aspx</link>
            <description>Five months after signing an agreement on sale and purchase the Foot-and-Mouth (FMD) vaccine factory in Cologne Bayer HealthCare AG and Intervet International bv have completed the acquisition. Both ...</description>
            <pubDate>5 July 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet develops prototype for mass application avian influenza vaccine</title>
            <link>http://www.intervet.com/news/2006-06-12_-_intervet_develops_prototype_for_mass_application_ai_vaccine.aspx</link>
            <description>A biotech breakthrough achieved by Akzo Nobel’s animal health business, Intervet, means that mass application of a dual vaccine against avian influenza and Newcastle Disease could be available in the ...</description>
            <pubDate>12 June 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet Dieter Lütticken Award - Intervet’s award to reduce the number of animals used in testing for development and production of animal veterinary medicines</title>
            <link>http://www.intervet.com/news/2006-05-29_-_intervet_dieter_luetticken_award_2006.aspx</link>
            <description>Intervet International bv offers the Dieter Lütticken award to promote scientists or life science research institutions working in research areas that serve the 3R-concept i.e. reducing, refining or replacing ...</description>
            <pubDate>29 May 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet supplies German zoos with avian influenza vaccine</title>
            <link>http://www.intervet.com/news/2006-04-27_-_intervet_supplies_german_zoos_with_ai_vaccine.aspx</link>
            <description>On initiative of several federal states, Germany has obtained the European Union’s permission to vaccinate birds in zoos against avian influenza. To show its commitment to the preservation and protection ...</description>
            <pubDate>27 April 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet supplies Avian Influenza vaccine from vaccine bank to government of Israel</title>
            <link>http://www.intervet.com/news/2006-03-29_-_intervet_supplies_ai_vaccine_to_israel.aspx</link>
            <description>On Monday March 20, 2006 Intervet shipped 4 million doses of Nobilis Influenza (strain H5N2) into Israel out of its vaccine bank. After receipt of the emergency order the product has been shipped within ...</description>
            <pubDate>29 March 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>FDA’s Approval of AQUAFLOR Marks New Era in Teamwork</title>
            <link>http://www.intervet.com/news/2006-03-14b.aspx</link>
            <description>The U.S. Food and Drug Administration’s recent approval of AQUAFLOR® (florfenicol) Type A Medicated Article for catfish marked a significant milestone in the industry’s combined efforts to make more products ...</description>
            <pubDate>14 March 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet supplies Avian Influenza vaccine to French Government</title>
            <link>http://www.intervet.com/news/2006-02-16_-_intervet_supplies_avian_influenza_vaccine_to_french_government.aspx</link>
            <description>Yesterday the French Ministry of Agriculture announced the intention to vaccinate outdoor ducks against Avian Influenza in three western parts of France (Landes, Loire atlantique and Vendée). The French ...</description>
            <pubDate>16 February 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet International bv acquires Foot and Mouth Disease vaccine factory from Bayer HealthCare AG</title>
            <link>http://www.intervet.com/news/2006-02-10_-_intervet_acquires_fmd_vaccine_factory_from_bayer.aspx</link>
            <description>Boxmeer, February 10, 2006 – Today, Intervet, the animal health business unit of Akzo Nobel, announced the agreement with Bayer HealthCare AG to acquire the Foot and Mouth Disease (FMD) vaccine factory ...</description>
            <pubDate>10 February 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Strategic initiatives deliver strong growth and basis for new platform Organon BioSciences</title>
            <link>http://www.intervet.com/news/2006-02-07-strategic-initiatives-deliver.aspx</link>
            <description>Boxmeer, the Netherlands, February 7, 2006 – Akzo Nobel NV has announced today that it intends to separate its pharmaceutical activities from its chemicals and coatings businesses. The aim is to create ...</description>
            <pubDate>7 February 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Partnerships, Industry Cooperation Important in Source Verification Of U.S. Cattle</title>
            <link>http://www.intervet.com/news/2006-02-01b.aspx</link>
            <description>Animal ID will challenge, redefine cattle industryVeterinarians and cattle producers and industry representatives said today that industry cooperation and partnerships will be critical in implementing ...</description>
            <pubDate>1 February 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough Animal Health Corporation Introduces New Product Application to Control Swine Respiratory Disease</title>
            <link>http://www.intervet.com/news/2006-01-27b.aspx</link>
            <description>Schering-Plough Animal Health Corporation has introduced Nuflor® Oral 2.3% Concentrate Solution, the broadest spectrum oral antibiotic available for the treatment of several major causes of swine respiratory ...</description>
            <pubDate>27 January 2006</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Millions to benefit from Intervet project in India</title>
            <link>http://www.intervet.com/news/2005-12-20_-_millions_to_benefit_from_intervet_project_in_india.aspx</link>
            <description>Arnhem, the Netherlands, December 19, 2005 – Akzo Nobel’s animal healthcare business, Intervet, has signed a Memorandum of Understanding to exclusively supply veterinary products for a special project ...</description>
            <pubDate>20 December 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough Animal Health Launches New Web Site for AQUAFLOR® (florfenicol) in U.S.</title>
            <link>http://www.intervet.com/news/2005-12-20b.aspx</link>
            <description>Schering-Plough Animal Health Corporation has launched a new web site to keep the U.S. aquaculture industry abreast of the latest developments with AQUAFLOR® (florfenicol), the first antibiotic approved ...</description>
            <pubDate>20 December 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough Animal Health Commemorates 50th Anniversary</title>
            <link>http://www.intervet.com/news/2005-11-30b.aspx</link>
            <description>Company Recognizes Veterinarians with Donation to American Veterinary Medical FoundationSchering-Plough Animal Health Corp. (SPAH), a global leader in advancing the health and welfare of animals, is celebrating ...</description>
            <pubDate>30 November 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet to support European Zoos</title>
            <link>http://www.intervet.com/news/2005-11-21_-_intervet_to_support_european_zoos.aspx</link>
            <description>Boxmeer, 21 November 2005 - In October the European Commission published a decision permitting the vaccination of zoo birds against bird flu, under certain conditions. The Dutch Government received EU ...</description>
            <pubDate>21 November 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough Receives First U.S. Approval for AQUAFLOR® (florfenicol)</title>
            <link>http://www.intervet.com/news/2005-11-11b.aspx</link>
            <description>First In-Feed Antibiotic for U.S. Aquaculture in More Than 20 YearsSchering-Plough Corporation (NYSE: SGP) today announced its Animal Health Division has received approval from the U.S. Food and Drug ...</description>
            <pubDate>11 November 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Schering-Plough Animal Health Lends Aid and Support to People and Pets Affected by Hurricane</title>
            <link>http://www.intervet.com/news/2005-09-22b.aspx</link>
            <description>Katrina Disaster Underscores Importance of Animal IdentificationSchering-Plough Animal Health Corp. (SPAH) today announced that it has contributed nearly $130,000 to aid Hurricane Katrina relief efforts ...</description>
            <pubDate>22 September 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Swiss scientist honored for excellent contribution to the principles of 3R's</title>
            <link>http://www.intervet.com/news/2005-08-22_-_swiss_scientist_honored_for_excellent_contribution_to_the_principles_of_3r_s.aspx</link>
            <description>August 22, 2005 – At the '5th World Congress on Alternatives', on 22 August in Berlin, Germany Prof. Andrew Hemphill, University of Bern, Switzerland was honored with the Intervet Dieter Lütticken Award ...</description>
            <pubDate>22 August 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Agreement reached for Intervet to acquire AgVax Developments Ltd, New Zealand</title>
            <link>http://www.intervet.com/news/2005-08-09_-_agreement_reached_for_intervet_to_acquire_agvax.aspx</link>
            <description>Boxmeer, the Netherlands, and Hamilton, NZ, August 9, 2005 - Intervet aims to extend its market presence in New Zealand with the acquisition of AgVax Developments Ltd., a highly successful animal health ...</description>
            <pubDate>9 August 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Citing Special Need, USDA Issues Conditional License for Poultry Industry’s First Vaccine for Necrotic Enteritis</title>
            <link>http://www.intervet.com/news/2005-07-25b.aspx</link>
            <description>Schering-Plough Animal Health Now Field Testing Product in USSchering-Plough Animal Health Corporation has obtained a conditional license from the U.S. Department of Agriculture to begin field testing ...</description>
            <pubDate>25 July 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet to divest part of feed additives business</title>
            <link>http://www.intervet.com/news/2005-06-07_-_intervet_to_divest_part_of_feed_additives_business.aspx</link>
            <description>Arnhem, the Netherlands, June 7, 2005 – Akzo Nobel’s animal healthcare business, Intervet, has agreed to divest some of its feed additives activities to Bulgarian company Biovet®. Both parties have agreed ...</description>
            <pubDate>7 June 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Announcement of new selection round Dieter Lütticken Award, Intervet’s annual award to reduce the number of animals used in testing for development and production of animal veterinary medicines</title>
            <link>http://www.intervet.com/news/2005-05-02_-_announcement_new_selection_round_dl_award.aspx</link>
            <description>Boxmeer, May 2005 – For the second year Intervet International bv, the animal health business of Akzo Nobel, offer the Dieter Lütticken award to promote scientists or life science research institutions ...</description>
            <pubDate>2 May 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Announcement of winner Dieter Lütticken Award, new annual prize to reduce the number of testing animals in veterinary medicines awarded to Prof. Andrew Hemphill, Switzerland</title>
            <link>http://www.intervet.com/news/2005-05-02_-_announcement_of_winner_dieter_l_tticken_award.aspx</link>
            <description>Boxmeer,  May 2005 – For the first time Intervet International bv, the animal health business of Akzo Nobel, award an excellent contribution to the principle of 3Rs for the development and production ...</description>
            <pubDate>2 May 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Success through focus - Intervet sales release</title>
            <link>http://www.intervet.com/news/2005-02-04_-_success_through_focus_-_intervet_sales_release.aspx</link>
            <description>Boxmeer, February 4, 2005 - With net sales of EUR 1,024 million Intervet met its targets for 2004, consolidating its position as one of the world's three biggest animal health companies. Sales as reported ...</description>
            <pubDate>4 February 2005</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>IDEXX Laboratories to purchase Bommeli Diagnostics</title>
            <link>http://www.intervet.com/news/2009-08-23-idexx-purchases-bommeli.aspx</link>
            <description>WESTBROOK, Maine, TBD, 2004-08-23—The Production Animal Services group of IDEXX Laboratories, Inc. (NASDAQ: IDXX), signed an agreement on August 17, 2004, for the purchase of Dr. Bommeli AG, a company ...</description>
            <pubDate>23 August 2004</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet India Commended For Its Commitment</title>
            <link>http://www.intervet.com/news/2004-06-21_-_intervet_india_commended_for_its_commitment.aspx</link>
            <description>Boxmeer, the Netherlands, June 18, 2004 – Last week, Intervet India received the Holland Award for its 'outstanding achievements in the field of International Agri-business in India and the Animal Health ...</description>
            <pubDate>21 June 2004</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Feed Additives Business transferred to Intervet</title>
            <link>http://www.intervet.com/news/2004-05-03_-_feed_additives_business_transferred_to_intervet.aspx</link>
            <description>Boxmeer/Stenungsund, May 3, 2004 - In order to provide better market alignment and to strengthen Akzo Nobel’s overall position in feed additives, Akzo Nobel has decided to consolidate the CRINA® and Bredol ...</description>
            <pubDate>3 May 2004</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet Dieter Lütticken Award - Intervet creates new award to reduce the number of animals used in testing for development and production of animal veterinary medicines</title>
            <link>http://www.intervet.com/news/2004-05-01-intervet-diieter-luetticken-award.aspx</link>
            <description>Boxmeer, May 2004 – Intervet International bv, the animal health business of Akzo Nobel, has set up a new Award to encourage scientists or life science research institutions to work in research areas ...</description>
            <pubDate>1 May 2004</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet maintains course despite economic headwinds</title>
            <link>http://www.intervet.com/news/2004-02-19_-_intervet_maintains_course_despite_economic_headwinds.aspx</link>
            <description>Boxmeer, Netherlands, February 19, 2004 – With total sales in 2003 of EUR 1,010 million, Intervet is well positioned to maintain its No. 3 position in the global animal health market despite the economic ...</description>
            <pubDate>19 February 2004</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet provides support to authorities' efforts to halt the spread of bird flu in Asia</title>
            <link>http://www.intervet.com/news/2004-02-02_-_intervet_provides_support_to_authorities__efforts_to_halt_the_spread_of_bird_flu_in_asia.aspx</link>
            <description>Boxmeer, the Netherlands, February 2, 2004 – Intervet, Akzo Nobel’s animal healthcare business, is providing local and international authorities support to combat the avian flu (Avian Influenza) epidemic ...</description>
            <pubDate>2 February 2004</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>All tools for emergency vaccination against Classical Swine Fever available after EU positively evaluates discriminatory antibody test</title>
            <link>http://www.intervet.com/news/2003-12-08_-_all_tools_for_emergency_vaccination_against_classical_swine_fever_available__english_.aspx</link>
            <description>Boxmeer, December 05, 2003 At the beginning of this month, the EU Standing Committee approved the EU Commission Decision on the positive evaluation of a discriminatory test for Classical Swine Fever (CSF). ...</description>
            <pubDate>8 December 2003</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Nobilis Salenvac T vaccine receives award at VIV Europe 2003</title>
            <link>http://www.intervet.com/news/2003-10-31_-_nobilis_salenvac_t_vaccine_receives_award_at_viv_europe_2003.aspx</link>
            <description>Boxmeer, October 19, 2003 - Nobilis Salenvac T, Intervet’s new vaccine that provides excellent protection for breeder and layer birds against Salmonella infections has received the VIV award in the category ...</description>
            <pubDate>31 October 2003</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Salenvac T vaccine spreads wings at VIV</title>
            <link>http://www.intervet.com/news/2003-10-23_-_salenvac_t_vaccine_spreads_wings_at_viv.aspx</link>
            <description>Boxmeer, September 1, 2003 - VIV 2003 is the first non-UK debut of Nobilis Salenvac T, Intervet’s salmonella vaccine that protects against both S.enteritidis and S.typhimurium, making it an important ...</description>
            <pubDate>23 October 2003</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Bommeli Diagnostics launches New CHEKIT-APP-AppIV Test</title>
            <link>http://www.intervet.com/news/2003-04-11_-_article_bommeli_diagnostics_launches_new_chekit-app-appiv_test.aspx</link>
            <description>Liebefeld-Bern, Switzerland -March 15, 2003- Bommeli Diagnostics, the diagnostic unit within Akzo Nobels veterinary business Intervet International bv today announced the launch of its new and improved ...</description>
            <pubDate>11 April 2003</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Vaccination against Avian Influenza</title>
            <link>http://www.intervet.com/news/2003-04-01_-_vaccination_against_avian_influenza.aspx</link>
            <description>Boxmeer, March 27, 2003 - The outbreak of Avian Influenza (fowl plague) in the Netherlands has sparked an ongoing debate about vaccination as an additional measure to control this viral disease. In principle, ...</description>
            <pubDate>1 April 2003</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Intervet weathered market challenges in 2002</title>
            <link>http://www.intervet.com/news/2003-03-13_-_intervet_weathered_market_challenges_in_2002.aspx</link>
            <description>Boxmeer, March 07, 2003 – Intervet’s excellent global coverage and its broad range of products for farm and companion animals put the company in a stable position to weather the year’s dips in the veterinary ...</description>
            <pubDate>13 March 2003</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 

         <item>
            <title>Background information on Avian Influenza outbreak</title>
            <link>http://www.intervet.com/news/2003-03-11_-_background_information_on_avian_influenza_outbreak.aspx</link>
            <description>Boxmeer, March 11, 2003 – On March 1, 2003, the Dutch government decided to place a ban on all transport and export of poultry and poultry related farming products following a suspicion of an avian influenza ...</description>
            <pubDate>11 March 2003</pubDate>
            <author>info@intervet.com (Intervet / Schering-Plough Animal Health)</author>
         </item> 
   
      </channel>
  </rss>
